Literature DB >> 22212478

Breathless cancer cells get fat on glutamine.

Dimitrios Anastasiou1, Lewis C Cantley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212478      PMCID: PMC3292290          DOI: 10.1038/cr.2012.5

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  13 in total

1.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

2.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.

Authors:  Christian M Metallo; Paulo A Gameiro; Eric L Bell; Katherine R Mattaini; Juanjuan Yang; Karsten Hiller; Christopher M Jewell; Zachary R Johnson; Darrell J Irvine; Leonard Guarente; Joanne K Kelleher; Matthew G Vander Heiden; Othon Iliopoulos; Gregory Stephanopoulos
Journal:  Nature       Date:  2011-11-20       Impact factor: 49.962

3.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

4.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

5.  Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Authors:  Ralph J DeBerardinis; Anthony Mancuso; Evgueni Daikhin; Ilana Nissim; Marc Yudkoff; Suzanne Wehrli; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

6.  Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor.

Authors:  M Ookhtens; R Kannan; I Lyon; N Baker
Journal:  Am J Physiol       Date:  1984-07

Review 7.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

8.  ATP-citrate lyase links cellular metabolism to histone acetylation.

Authors:  Kathryn E Wellen; Georgia Hatzivassiliou; Uma M Sachdeva; Thi V Bui; Justin R Cross; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

9.  Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability.

Authors:  David R Wise; Patrick S Ward; Jessica E S Shay; Justin R Cross; Joshua J Gruber; Uma M Sachdeva; Jesse M Platt; Raymond G DeMatteo; M Celeste Simon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 12.779

10.  Reductive carboxylation supports growth in tumour cells with defective mitochondria.

Authors:  Andrew R Mullen; William W Wheaton; Eunsook S Jin; Pei-Hsuan Chen; Lucas B Sullivan; Tzuling Cheng; Youfeng Yang; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Nature       Date:  2011-11-20       Impact factor: 69.504

View more
  33 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Authors:  Andrew R Mullen; Zeping Hu; Xiaolei Shi; Lei Jiang; Lindsey K Boroughs; Zoltan Kovacs; Richard Boriack; Dinesh Rakheja; Lucas B Sullivan; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

Review 3.  Marine microbial L-glutaminase: from pharmaceutical to food industry.

Authors:  Noora Barzkar; Muhammad Sohail; Saeid Tamadoni Jahromi; Reza Nahavandi; Mojgan Khodadadi
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-27       Impact factor: 4.813

Review 4.  Pheochromocytoma: The First Metabolic Endocrine Cancer.

Authors:  Ivana Jochmanova; Karel Pacak
Journal:  Clin Cancer Res       Date:  2016-10-15       Impact factor: 12.531

Review 5.  Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2012-09-26       Impact factor: 7.376

6.  Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Immunology       Date:  2015-07-27       Impact factor: 7.397

7.  Model of vascular desmoplastic multispecies tumor growth.

Authors:  Chin F Ng; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2017-05-18       Impact factor: 2.691

8.  PEG-PHB-glutaminase nanoparticle inhibits cancer cell proliferation in vitro through glutamine deprivation.

Authors:  Sureshbabu Ram Kumar Pandian; Venkataraman Deepak; Hariharan Nellaiah; Krishnan Sundar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-26       Impact factor: 2.416

Review 9.  Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis.

Authors:  Haifeng Zhao; Phyllis A Dennery; Hongwei Yao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

Review 10.  Metabolomics in rheumatic diseases: desperately seeking biomarkers.

Authors:  Monica Guma; Stefano Tiziani; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2016-03-03       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.